Abruzzo Dental Forum 2026 on AI and digital dentistry

That matters economically because dental practices are increasingly being asked to do more with less: faster workflows, higher diagnostic accuracy and more standardized treatment planning. Technologies such as intraoral scanners and CAD/CAM systems can shorten chair time, reduce manual steps and support lab-to-clinic integration, while AI-assisted diagnostics can help practices handle rising complexity and patient expectations.

For manufacturers and suppliers, the forum doubles as a commercial meeting point. The exhibition area brings together companies, professionals and innovators, offering a local sales and networking platform for digital imaging, software and device vendors targeting a sector that is still investing in modernization.

The event also reflects a broader tension in healthcare technology: adoption is accelerating, but professional groups are keen to insist that software supports, rather than replaces, clinical expertise. ANDI Abruzzo president Luca De Santis and cultural secretary Arturo Marrone both framed the central challenge as using innovation in a controlled way that keeps the patient and clinician at the center of care.

For investors watching medtech and dental-equipment names, the backdrop is a market that continues to reward companies tied to digitization, workflow automation and AI-enabled diagnostics, even as any near-term pullback in the stock of dental and imaging firms can reflect broader volatility rather than a change in the adoption story. Shares of X-ray equipment maker Dentsply Sirona have fallen to $8.89, while 3D Systems-backed dental workflow platforms and robotic surgery leader Intuitive Surgical remain tied to the same long-term theme of precision care and automation, with the latter still trading at $408.72 after a sharp run-up earlier in the summer.

The immediate takeaway from Montesilvano is that dentistry is still in the middle of a capital and workflow transition. The next catalysts will be whether practices convert interest in AI and digital imaging into actual purchasing, and whether suppliers can prove that the technology cuts costs, speeds treatment and improves outcomes without raising complexity.